Reasons to Retain Stryker Stock in Your Portfolio for Now
ZacksSYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.